Finance

Beta
Lists
BRKR:NASDAQ
Bruker Corp
$60.91
+0.03%
(+0.020) 1D
$60.91
0.00% (0.00)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRKR...
Open
$60.40
High
$61.17
Low
$59.79
Mkt. cap
9.27B
Avg. vol.
2.84M
Volume
2.32M
Dividend
0.33%
Quarterly dividend
$0.05
Ex-dividend date
Mar 23, 2026
52-wk high
$64.54
52-wk low
$28.53
EPS
-$0.24
Beta
1.31
Shares outstanding
152.23M
No. of employees
11K
Open
$60.40
High
$61.17
Low
$59.79
Mkt. cap
9.27B
Avg. vol.
2.84M
Volume
2.32M
Dividend
0.33%
Quarterly dividend
$0.05
Ex-dividend date
Mar 23, 2026
52-wk high
$64.54
52-wk low
$28.53
EPS
-$0.24
Beta
1.31
Shares outstanding
152.23M
No. of employees
11K
News stories
From sources across the web
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOFrank Laukien
Employees11.1K
Founded1960
HeadquartersBillerica, Massachusetts, United States
SectorHealth care
Websitebruker.com
Analyst ratings
Based on 9 analysts giving stock ratings to BRKR in the past 3 months
Buy
Buy
4
Hold
5
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for BRKR in the last 3 months.
Highest
Current $60.91
$65.00 (+6.71%)
Average
$52.38 (-14.00%)
Lowest
$44.00 (-27.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Reiterated
$60.00
-1.5%
06/24/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
$65.00
+6.7%
06/08/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
$65.00
+6.7%
06/02/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
$45.00
-26.1%
05/08/2026
Dan Leonard
RBC Capital
Hold
Reiterated
$45.00
-26.1%
05/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$50.00
-17.9%
05/06/2026
Patrick B Donnelly
Citi
Hold
Maintained
$44.00
-27.8%
05/07/2026
Kyle Boucher
TD Cowen
Hold
Reiterated
$45.00
-26.1%
05/07/2026
Evie Koslosky
Goldman Sachs
Sell
Maintained
$35.00
-42.5%
02/13/2026
Daniel Brennan
TD Cowen
Hold
Maintained
$43.00
-29.4%
02/13/2026
Tycho Peterson
Jefferies
Buy
Maintained
$50.00
-17.9%
02/12/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.31 / $0.23
+34.81%beat
Revenue / Est. (USD)
823.40M / 795.67M
+3.48%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
797.40M
860.50M
977.20M
823.40M
Cost of goods sold
432.30M
446.30M
510.40M
428.20M
Cost of revenue
432.30M
446.30M
510.40M
428.20M
Research and development expenses
100.20M
98.30M
99.60M
101.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.40M
242.50M
244.20M
242.10M
Operating expense
336.30M
302.70M
402.50M
344.30M
Total operating expenses
768.60M
749.00M
912.90M
772.50M
Operating income
28.80M
111.50M
64.30M
50.90M
Other non operating income
200.00K
9.30M
-5.70M
3.00M
EBT including unusual items
1.10M
-72.60M
67.00M
18.20M
EBT excluding unusual items
18.00M
106.60M
54.20M
47.30M
Income tax expense
-3.10M
-14.10M
37.80M
2.50M
Effective tax rate
-281.82%
19.42%
56.42%
13.74%
Other operating expenses
4.70M
-38.10M
58.70M
800.00K
Net income
7.60M
-59.60M
26.00M
14.40M
Net profit margin
0.95%
-6.93%
2.66%
1.75%
Earnings per share
0.32
0.45
0.59
0.31
Interest and investment income
2.70M
4.40M
4.60M
4.90M
Interest expense
-15.70M
-20.30M
-11.20M
-12.20M
Net interest expenses
-13.00M
-15.90M
-6.60M
-7.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
84.90M
167.20M
122.40M
109.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of BRKR
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more